United States Autoimmune Disorders Diagnostics Market Report

1
Un i ted S t a tes Auto i m m un e D i s o
rders D i a g n o s t i c s Market Oppo rt un i t
i es , 2020
P h a r m a H e a l t h c a r e C o n
s u l t a n t s
2
2
R e s e a r c h M e t h o d o l o g y
United States Autoimmune Disorders Diagnostics
Market
Secondary Sources
Primary Sources
Identifying Key Opinion Leaders Questionnaire
Design In-depth Interviews Coverage across
Value Chain market
Government websites Company annual reports,
white papers, investor presentations and
financial reports
Data Collection
Qualitative and Quantitative Research
Data Validation, Analysis and Interpretation
Data validation through Primary Secondary
outreach, data analysis and interpretation of
key findings
Market Estimation Forecasting ?Bottom-Up or
Top-down approach for Market size
estimation ?Historical trend examination ?Impact
analysis of drivers and challenges to market
growth ?Statistical evaluation to develop the
actual forecast CAGR (2015E-2020F) XX 7
Pharmaion 2015E 2016F 2017F 2018F 2019F
2020F
3
R e s e a r c h M e t h o d o l o g y
Baseline Methodology For the study of United
States autoimmune disorders diagnostics market,
Pharmaion has gathered information through an
exhaustive search of credible databases prudently
evaluated all the collected information and
presented it in the most accurate and detailed
manner. Primary Research
Qualitative and quantitative data from company
website, financial reports, research articles,
designed questionnaires etc.

• Key Stakeholders
• Product/Brand Managers
• Business Development Managers
• Regional Mangers
• Regulatory Affairs Personnel
• Marketing Sales Managers
• Head of Patient Support Programme

In-depth interviews of key stakeholders of
major companies
Data Triangulation (Data validation through
cross verification from primary secondary
sources)
Secondary Research

• Analysis of Data from credible sources
• Centers for Disease Control and Prevention (CDC)
• WHO Reports

• American Autoimmune Related Diseases Association
  (AARDA)

Substantial data points for analysis,
interpretation and market size estimation

• American College of Rheumatology

3

• National Institute of Arthritis and
  Musculoskeletal and Skin Diseases

Pharmaion
4

• R e s e a r c h M e t h o d o l o g y
• United States Autoimmune Disorders Diagnostics
  Market - Market Size Estimation
• United States autoimmune disorders diagnostics
  market has been segmented into two segments
  systemic autoimmune disorders diagnostics and
  localized autoimmune disorders diagnostics.
• Further, the United States autoimmune disorders
  diagnostics market has been categorized into
  seven sub-segments Anti-Nuclear Antibody Test,
  Complete Blood Count Test, Erythrocyte
  Sedimentation Rate (ESR), C-reactive protein,
  Comprehensive Metabolic Panel, Urinalysis and
  Others
• Anti-Nuclear antibody tests market have been
  further classified into three sub segments ENA
  Panel, Anti-dsDNA and Others (Anticentromere
  Antibody, Histone Antibody, Nucleolar Antibody,
  etc.).

Calculation of market size of the US autoimmune
disorders diagnostics market
CAGR of forecast period obtained from the
primary and secondary outreach applied on the
given market
Top-down Approach
By Target Disease, Test Technology Market Size
Respective Market Share (From Primary and
Secondary Research) X Total Market Value
Calculation of Sub- segment market size
Calculation of regional market size
Regional Market Size Respective Market Share
(From Primary and Secondary Research) X Total
Market Value
4
Pharmaion
5
T a b l e
o f C o n t e n t s
S No. Contents Contents Contents
1. Autoimmune Disorders Diagnostics Overview Autoimmune Disorders Diagnostics Overview Autoimmune Disorders Diagnostics Overview
2. Research Methodology Research Methodology Research Methodology
3. Analyst View Analyst View Analyst View
4. Disease Epidemiology Disease Epidemiology Disease Epidemiology
4. Global Autoimmune Disorders Diagnostics Market Overview Global Autoimmune Disorders Diagnostics Market Overview Global Autoimmune Disorders Diagnostics Market Overview
5. United States Autoimmune Disorders Diagnostics Market Outlook United States Autoimmune Disorders Diagnostics Market Outlook United States Autoimmune Disorders Diagnostics Market Outlook
5.1. Market Size Forecast Market Size Forecast
5.1.1. By Value
5.2. Market Share Forecast Market Share Forecast
5.2.1. By Target Disease (Systemic Autoimmune Disorders Diagnostics Localized Autoimmune Disorders Diagnostics)
5.2.2. By Test (Urinalysis, Comprehensive Metabolic Panel, C-reactive Protein, Erythrocyte Sedimentation Rate, Complete Blood Count, Anti-Nuclear Antibody Test Others)
5.2.3. By Technology (Enzyme Immunoassay, Multiplexed Immunoassays, Immunofluorescence Others)
5.2.4. By Region (South-West, West, North-East, Midwest, South-East)
6. United States Anti-Nuclear Antibody Test Market Outlook United States Anti-Nuclear Antibody Test Market Outlook United States Anti-Nuclear Antibody Test Market Outlook
6.1. Market Size Forecast Market Size Forecast
6.1.1. By Value
6.2. Market Share Forecast Market Share Forecast
6.2.1. By Type Others (Anti-centromere Antibodies, Histone Antibody Nucleolar Antibody), Anti- dsDNA Test ENA Panel
7. Market Dynamics Market Dynamics Market Dynamics
7.1. Drivers Drivers
7.2. Challenges Challenges
5
Pharmaion
6
T a b l e
o f C o n t e n t s
S No. Contents Contents Contents
8. Market Trends Developments Market Trends Developments Market Trends Developments
8.1. Increasing Use of Biomarkers Increasing Use of Biomarkers
8.2. Lab automation Lab automation
8.3. Lab-on- Chip Device Lab-on- Chip Device
8.4. Portable Diagnostic Equipment Portable Diagnostic Equipment
8.5. Partnership with Physician and Diagnostic Laboratories Partnership with Physician and Diagnostic Laboratories
9. Policy Regulatory Landscape Policy Regulatory Landscape Policy Regulatory Landscape
10. United States Economic Profile United States Economic Profile United States Economic Profile
11. Competitive Landscape Competitive Landscape Competitive Landscape
11.1. Competition Benchmarking (Market Attractiveness) Competition Benchmarking (Market Attractiveness)
11.2. Company Profiles Company Profiles
11.2.1. Bio-Rad Laboratories, Inc.
11.2.2. Roche Diagnostics Corporation
11.2.3. Abbott Laboratories
11.2.4. Danaher Corporation
11.2.5. Siemens Healthcare Diagnostics, Inc.
11.2.6. Biomeriux Clinical Diagnostics
11.2.7. Immco Diagnostics
11.2.8. Beckton Dickson
11.2.9. Alere Inc.
11.2.10. Inova Diagnostics, Inc.
12. Strategic Recommendations Strategic Recommendations Strategic Recommendations
13. About Us Disclaimer About Us Disclaimer About Us Disclaimer
3
Pharmaion
7
I n d u s t r y B r i e f
United States Autoimmune Disorders Diagnostics
Market to Surpass US 6 Billion by 2020 Growing
prevalence of autoimmune disorders and various
ongoing technological advancements to drive
the United States autoimmune disorders
diagnostics market According to recently
published Pharmaion report, United States
Autoimmune Disorders Diagnostics Market
Opportunities, 2020,the autoimmune disorders
diagnostics market in the United States is
anticipated to cross US 6 billion by 2020. Some
of the major autoimmune diseases include
Rheumatoid Arthritis, Type 1 Diabetes, Multiple
Sclerosis, Systemic Lupus Erythematosus (SLE),
Inflammatory Bowel Disease (IBD), Psoriasis and
Autoimmune Thyroiditis, etc. According to
American Autoimmune Related Diseases Association
(AARDA), 50 million Americans are suffering from
more than 100 types of autoimmune disorders, and
75-85 of the total autoimmune disorders patients
in the country are women. Growth in the market
is anticipated on account of growing disease
burden of various autoimmune disorders,
increasing healthcare expenditure and various
ongoing technological advancements. Moreover,
increasing automation in laboratories leading to
precise and faster diagnosis is forecast to
further fuel the market of autoimmune disorders
diagnostics in the United States during 2015 -
2020.On the basis of target disease, the market
is broadly segmented into two categories, namely,
systemic autoimmune disorders diagnostics and
localized autoimmune disorders diagnostics. Among
these two categories, systemic autoimmune
disorders diagnostics segment dominated the
United States autoimmune disorders diagnostics
market in 2014, and the segment is anticipated to
continue its dominance through 2020 on account of
increasing ongoing research activities that are
focused on developing tests and technologies that
would precisely detect the abnormalities in
organ functioning and deliver faster diagnosis.
With growing adoption of biomarkers, Lab-on-Chip
devices and portable diagnostic equipment, the
market for autoimmune disorders diagnostics in
the United States is anticipated to grow over the
next five years. Moreover, National Institute of
Allergy and Infectious Diseases (NIAID) is
organizing a clinical research program -
Autoimmunity Centre of Excellence (ACEs) for
effective diagnosis and treatment of autoimmune
diseases by expanding collaborative research
across medical specialties, scientific
disciplines, and basic clinical scientists.",
said Mr. Karan Chechi, Research Director of
Pharmaion, a research based global
pharmaceutical and healthcare consulting firm.
7
Pharmaion
8
P r o d u c t O v e r v i e w Autoimmune
disorders occur when a persons immune system
attacks his/her own body and for detecting
these disorders and prescribing required
treatments, various laboratory tests are
performed. On the basis of disorder type,
autoimmune disorders diagnostics market in the US
has been segmented into two categories, namely,
systemic autoimmune disorders diagnostics and
localized autoimmune disorders diagnostics. Auto
immune Disorders Diagnostics Market
Localised Autoimmune Disorders Diagnostics
Systemic Autoimmune Disorders Diagnostics
Systemic Autoimmune Disorders Diagnostics They
are non-organ specific disease which affects
multiple organs and tissues of the body is known
as systematic autoimmune disorder. It broadly
involves the diagnosis of diseases, such as
Systemic Lupus Erythematosus (SLE), Rheumatoid
Arthritis, Ankylosing Spondylitis, etc., which
are mainly diagnosed by rheumatologists and
clinical immunologists. Localised Autoimmune
Disorders Diagnostics They are organ specific
disease which effects single organ or tissue of
the body and are diagnosed mainly by
rheumatologists, endocrinologists and
neurologists. It mainly involves the diagnosis
of diseases like Multiple Sclerosis, Inflammatory
Bowel Disease (IBD), Type 1 Diabetes, Thyroid,
etc. 6
Pharmaion
9
Sample Data - Snapshot
United States Average Annual Cost of Diagnosis
and Treatment of Autoimmune Disorders, 2014
United States Autoimmune Disorders Diagnostics
Market Share, By Test, By Value,
2010-2020F 35.01 35.02 35.03 35.04 35.05 35.0
6 35.07 35.08 35.09 35.10
35.00
Autoimmune Disorder Annual Cost per Patient (USD)
X X
X X
X X
X X
X X
17.00 17.01 17.02 17.03 17.04 17.05 17.06 17.07 17.08 17.09 17.10
14.00 14.01 14.02 14.03 14.04 14.05 14.06 14.07 14.08 14.09 14.10
9.00 9.01 9.02 9.03 9.04 9.05 9.06 9.07 9.08 9.09 9.10
8.00 8.01 8.02 8.03 8.04 8.05 8.06 8.07 8.
08 8.09 8.10 6.00 6.01 6.02 6.03 6.04 6.05
6.06 6.07 6.08 6.09 6.10 3.00 3.0 3.02 3
.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10
2020F
2010 2011 2012 2013 2014 2015E Anti-Nuclear
Antibody Test Erythrocyte Sedimentation Rate
(ESR)
2016F 2017F 2018F 2019F Complete Blood Count
(CBC) C-reactive Protein
United States Autoimmune Disorders
Diagnostics Market Size, By Value, 2010-2020F
(USD Billion)
12
11
10
United States Autoimmune Disorders Diagnosis
Market Share, By Region, By Value, 2014 2020F
5
7 8 9
2 3 4
1
West
2010 2011 2012 2013 2014 2015E 2016F
2017F 2018F 2019F 2020F
Midwest
North- East
2014 X
SEGMENTAL REVENUE BREAK UP, 2014 By Business
Segments By Geography
2020F X
2014 X 2020F X
2014 X 2020F X
Life Science,
Unites States, 50.00
Other Countries, 50.00
50.00 Clinical Diagnosti cs, 50.00
United States Autoimmune Disorders Prevalence per
150
100,000 Population, 2013
100
South- East
South- West
50
2014 X 2020F X
9 Pharmaion
2014 X 2020F X
Diabetes Type 1
Systemic Lupus Rheumatoid Arthritis Erthymatosus
(SLE)
10
Report Name United States Autoimmune Disorders
Diagnostics Market Opportunities, 2020
R e p o r t O r d e r i n g
Report Price
License Type Price
Single User License 3000
Single User License Print 3500
Enterprise License 5000
To View Sample OR Purchase Report
10
11
A b o u t U s D i s c l a i m e r About Us
Pharmaion is a research based management
consulting firm focused exclusively on Healthcare
Pharmaceutical industry. Pharmaions core
values are value, integrity and insight. Led by a
team of dynamic industry experts, Pharmaion
provides its customers with high value market
research and advisory services that helps them
identify new market opportunities, growth engines
and innovative ways to capture the market share.
As a result, Pharmaions clients lead rather than
follow market trends. Not bound by legacy,
Pharmaions cutting-edge research model leverages
its decades of research knowledge and an
increased use of technology as engines of
innovation to deliver unique research value.
Provided as an alternative to traditional market
research, Pharmaions reports do not just
deliver data and knowledge rather highlights the
insights in a more usable and interactive format
for its clients. Pharmaion is committed to
assisting customers worldwide with their unique
market research needs by providing them with
comprehensive, value-added solutions and
professional market intelligence services.
Pharmaion employs the industrys best-trained
industry Analysts and Consultants, which advises
and assists customers in meeting their full
service market research and consulting
requirements. Related Reports India Stem Cell
Market Opportunities, 2020 Global Tissue
Engineered Medical Devices Market Opportunities,
2020 Global Cervical Cancer Vaccine Market
Opportunities, 2020 Disclaimer The contents of
this report are based on information generally
available to the public from sources believed to
be reliable. No representation is made that it
is timely, accurate or complete. Pharmaion
Consultants has taken due care and caution in
compilation of data as this has been obtained
from various sources including which it
considers reliable and first hand. However,
Pharmaion Consultants does not guarantee the
accuracy, adequacy or completeness of any
information and it is not responsible for any
errors or omissions or for the results obtained
from the use of such information and especially
states that it has no financial liability
whatsoever to the subscribers / users of this
report. The information herein, together with all
estimates and forecasts, can change without
notice. All the figures provided in this document
are indicative of relative market size and are
strictly for clients internal consumption.
Usage of the same for purpose other than internal
will require prior approval of Pharmaion
Consultants.
NORTH AMERICA Pharmaion Consultants LLC 708 3RD
Avenue, 6th Floor, New York, NY, United State,
10017 sales_at_pharmaion.com 1 646 360
1656 www.pharmaion.com
ASIA PACIFIC Pharmaion Consultants Pvt. Ltd. A
51, Sector 57, Noida, National Capital
Region, India - 201301 sales_at_pharmaion.com 91 -
120 - 452 3900 www.pharmaion.com
11 Pharmaion